Brief: Bergenbio Provides COVID-19 Impact Assessment
27/03/2020 15:42
March 27 (Reuters) - Bergenbio ASA BGBIO.OL :
* BERGENBIO PROVIDES COVID-19 IMPACT ASSESSMENT
Source text for Eikon: ID:nWkrc9G0q0
Further company coverage: BGBIO.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Oncoinvent ASA
See all newsBrief: Oncoinvent To Raise Up To NOK 140 Million In Private Placement
Brief: Oncoinvent H1 Operating Loss NOK 69 Mln
Brief: Oncoinvent Secures New Patent Expanding Protection For Radspherin
Brief: Oncoinvent's Shares To Be Consolidated In Ratio Of 100:1
Brief: Oncoinvent To Increase Share Capital In Connection With Settlement Of Underwriting Fee